FullDNA
PrivateLast Round
Angel
Aug 29, 2022
Est. Valuation
$70M
Total Funding Raised
$21M
Company Overview
FullDNA operates in Healthcare & Life Sciences and is based in Kfar Saba. Its latest recorded funding round was an Angel round in August 2022.
FullDNA is a health tech company that provides an AI-based, customizable genetics prediction platform for health professionals to analyze DNA and predict health-related risks.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FullDNA Comparables
Compare FullDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneyx | 77% | |
| SeqOne | 74% | |
| Qiagen | 73% |
For institutional investors. Book with your work email.
FullDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Aug 29, 2022 | ||||
| VC Round | Jul 1, 2020 | ||||
| Accelerator | Jan 1, 2020 |
For institutional investors. Book with your work email.
FullDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Southern Israel Bridging Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2020
Completed an Accelerator round of funding.
For institutional investors. Book with your work email.
FullDNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FullDNA's valuation, stock price, and market status.
Is FullDNA a public or private company?
FullDNA is a private company.
What is the current stock price of FullDNA?
FullDNA is a private company, so its shares have no public market price. Caplight tracks FullDNA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FullDNA worth (valuation)?
FullDNA's valuation is estimated at $70.0M based on funding round data.
Can I buy FullDNA stock?
FullDNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FullDNA's last funding round?
FullDNA's most recent funding round was Angel on August 29, 2022.
Who are the main investors in FullDNA?
Key investors in FullDNA include Southern Israel Bridging Fund.
Will FullDNA IPO soon?
No public IPO plans have been announced for FullDNA.
How can I track FullDNA secondary market activity?
Caplight tracks bids, offers, and trades in FullDNA's shares on secondary markets.